Acutaas Chemicals Ltd Board Meeting Scheduled for April 30, 2026; Trading Window Updates
Acutaas Chemicals Ltd, formerly known as Ami Organics Limited, has scheduled a meeting of its Board of Directors for Thursday, April 30, 2026. The Board Meeting will take place at the Company’s Registered Office and is set to consider several key corporate matters.The meeting agenda includes considering and approving the Audited Standalone and Consolidated Financial Statements and Results for the fourth quarter and the financial year ended on March 31, 2026. Furthermore, the Board is expected to consider the recommendation of a Final Dividend for the Financial Year 2025-26. This dividend recommendation is subject to the subsequent approval by members at the Annual General Meeting. The meeting will also cover other business matters.
The Board Meeting will be preceded by an Audit Committee Meeting held on the same day.
In addition to the corporate governance updates, the company issued details regarding the trading window for its shares. The trading window for designated persons has been closed from April 1, 2026, until 48 hours after the declaration of the financial results for the fourth quarter and year ended March 31, 2026. Consequently, the trading window remains closed until Saturday, May 02, 2026, and is scheduled to reopen on Monday, May 4, 2026.
ACUTAAS Stock Price Movement
Shares of Acutaas Chemicals Limited are edging higher to ₹2461.8 as of 10:44 AM today, having gained 2.79% in live trading. The momentum remains strong, with 96,797 shares having been traded during the morning session.Disclaimer: Due care and diligence have been taken in compiling and presenting news and market-related content. However, errors or omissions may arise despite such efforts.
The information provided is for general informational purposes only and does not constitute investment advice, a recommendation, or an offer to buy or sell any securities. Readers are advised to rely on their own assessment and judgment and consult appropriate financial advisers, if required, before taking any investment-related decisions.
Any views, opinions, or statements expressed, where applicable, are those of the respective analysts or experts and do not reflect the views of this website. The website has no association with such viewpoints and does not assume any responsibility for them.